Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Grant/Award of 4,255 NAGE shares, $11.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 4,255 | $11.5K |
| Feb 24, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 62,131 | n/a |
| Nov 17, 2025 | Niagen Bioscience, Inc. (NAGE) | Purchase | 4,465 | $30.4K |
| Feb 14, 2025 | ChromaDex Corp. (CDXC) | Grant/Award | 17,230 | n/a |
| Nov 25, 2024 | ChromaDex Corp. (CDXC) | Purchase | 2,907 | $21.4K |
| Oct 23, 2024 | ChromaDex Corp. (CDXC) | Grant/Award | 146,544 | n/a |
| Sep 6, 2023 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 15,000 | n/a |
| May 19, 2023 | 180 Life Sciences Corp. (ATNF) | Purchase | 5,162 | $5.2K |
| Dec 13, 2021 | 180 Life Sciences Corp. (ATNF) | Purchase | 3,800 | $14.7K |
| Mar 3, 2021 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 180,000 | n/a |